netFormulary Portsmouth and South East Hampshire NHS
Prescribing Formulary  
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
Chapter Links...
 Details...
08.03.04.01  Expand sub section  Breast cancer
Anastrozole
(tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Recommended
 
Link  NICE CG 164 Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer
Link  NICE CG 81 Advanced breast cancer: diagnosis and treatment
Link  NICE NG101: Early and locally advanced breast cancer: diagnosis and management
   
Exemestane
(tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Recommended
 
Link  NICE CG 81 Advanced breast cancer: diagnosis and treatment
Link  NICE NG101: Early and locally advanced breast cancer: diagnosis and management
   
Fulvestrant (Faslodex)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
 
Link  NICE TA239: Fulvestrant for the treatment of locally advanced or metastatic breast cancer
Link  NICE TA579 Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
Link  NICE TA593: Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer
Link  NICE TA619 Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer
   
Goserelin (Zoladex)
(Implant)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Recommended
 
   
Letrozole
(tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Recommended
 
Link  NICE CG 81 Advanced breast cancer: diagnosis and treatment
Link  NICE NG101: Early and locally advanced breast cancer: diagnosis and treatment
   
Palbociclib  (Ibrance)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine

Approved in accordance with NICE TA495, in combination with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.

 
Link  NICE TA495: Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Link  NICE TA619 Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer
   
Ribociclib  (Kisqali)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red
High Cost Medicine
Cancer Drugs Fund

Approved in accordance with the Cancer Drugs Fund and NICE TA496 in combination with an aromatase inhibitor for the treatment of postmenopausal woman with previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer.

 
Link  NICE TA 593: Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer
Link  NICE TA496: Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
   
Tamoxifen
(tablets, oral solution)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber Recommended
 
Link  NICE CG 164 Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer
Link  NICE CG 81 Advanced breast cancer: diagnosis and treatment
Link  NICE NG101: Early and locally advanced breast cancer: diagnosis and treatment
   
 ....
 Non Formulary Items
Toremifene  (Fareston)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Primary and Secondary Care (unrestricted) may be prescribed by GPs, hospital doctors or other qualified prescribers in primary and secondary care  

Amber Initiation

Amber Initiated: first prescription from specialist, on going supplies from primary care (or when stabilised on therapy).  

Amber Recommended

Amber recommended: first prescription may be supplied by primary care under the advice of a specialist.  

Amber with Shared Care

For initiation within a specialist service followed by ongoing prescribing in primary care according to published shared care guidance  

Red

For initiation and ongoing prescribing in secondary care only. Medicines in this category may be further restricted to use by specific hospital departments only.  

Blue

For prescribing in primary care only  

netFormulary